EVERSANA is a proud sponsor of the World Drug Safety Congress Europe, October 9-10 in Amsterdam and the World Drug Safety Congress Americas taking place October 29-30 in Boston.
Visit Our Booths
Stop by our booths at these events to meet with EVERSANA experts and discover more about our Integrated Pharmacovigilance Solution. You can also schedule a meeting with our team to dive deeper into how our solution can benefit your organization.
- WDSC Europe: Booth #37
- WDSC Americas: Booth #427
Speaking Opportunities
WDSC Europe
- “The Subtle Art of Simplifying Pharmacovigilance”
- Wednesday, October 9 from 14:25-15:20
- Patient Centricity Track
- Room G106
- Moderated by Dr. Vivek Ahuja, Senior Vice President, Compliance Services, EVERSANA, with Pav Rishiraj, Director, Pharmacovigilance (UK & Ireland) & ABPI Board SG Member/PV Expert Chair, Ipsen, Dr. Uwe Gudat, Chief Medical Officer, Biocon Biologics, and Dr. Stewart Geary Chief, Medical Officer, Eisai Corporation
- Listen in on how to:
- Be Techno-zealous, overcome Ai-nxiety
- Unlock Efficiency Through Consolidation of people, process and technology
- Streamline Vendor Engagement – don’t drown in vendor diversity
- Solve the success trifecta – cost, quality, compliance
- “To AI or Not to AI”
- Wednesday, October 9 from 15:45-16:05
- PV Outsourcing Track
- Presented by Dr. Vivek Ahuja
- Room G109
- Dr. Vivek’s presentation transcends the routine presentation; it is not merely a presentation, but a compelling narrative. And this narrative is no fiction—it is a vivid, real-world account. It tells the story of a delicate balance: on one hand, we grapple with technophobia, while on the other, we stand on the brink of unprecedented technological advancement, hurtling forward at such a breakneck speed that the fear of being left behind becomes palpable. There is a relevant use case also interwoven in this narrative. Immerse yourself in this journey —it’s an unfolding tale of our times.
WDSC Americas
- “To AI or Not to AI” presented by Dr. Vivek Ahuja on Wednesday, October 30 from 12:25-12:45PM
- Dr. Vivek’s presentation transcends the routine presentation; it is not merely a presentation, but a compelling narrative. And this narrative is no fiction—it is a vivid, real-world account. It tells the story of a delicate balance: on one hand, we grapple with technophobia, while on the other, we stand on the brink of unprecedented technological advancement, hurtling forward at such a breakneck speed that the fear of being left behind becomes palpable. There is a relevant use case also interwoven in this narrative. Immerse yourself in this journey —it’s an unfolding tale of our times.
About EVERSANA’s Integrated Pharmacovigilance Solution
EVERSANA’s Integrated Pharmacovigilance Solution combines advanced technology with human expertise to streamline and enhance pharmacovigilance activities. Our solution employs automation, artificial intelligence, data analytics, and ACTICS by EVERSANA™ to create an efficient, cost-effective and compliant experience. Key features of this solution include:
- Simplified and Automated Approach: Seamlessly integrates automation, AI, data, analytics and human involvement to simplify processes.
- Regulatory Compliance and Financial Impact: Ensures regulatory compliance while optimizing resources, speeding up processes and reducing costs per case.
- Reduced Risk with Flexibility: Adapts to the specific needs of each organization and product life cycle phase, minimizing vendor-switching risks.
- High-Tech, High-Touch Approach: Combines AI and human interaction for a personalized approach, setting us apart from automation-only vendors.
- Comprehensive Integration of PV Services: Includes automated case processing, aggregate reporting, signal detection, literature monitoring, translations and QPPV services.
- Automated Data Processing: Automates a significant portion of data processing tasks, including regulatory authority cases, forms, articles and email complaints, literature monitoring, data migration, validity checks and reporting. Human intervention is limited to translation, quality checks and medical reviews.
- Efficiency Improvements: Reduces processing times to 3-5 days and cuts costs per case by 50%.
- Proven Capabilities: Validated through client implementations, testing and hazard analysis, using machine learning benchmarks for reliability.
- Global Execution and Flexibility: Suitable for companies of all sizes and disease states, covering all product life cycle stages from pre-clinical to post-product launch.
Join us at these events to learn how EVERSANA can help you ensure the safety of your product portfolios and the well-being of patients. We look forward to seeing you there!